✦ LIBER ✦

Barriers to clinical trials: Part I: Reimbursement problems

✍ Scribed by Irvin D. Fleming

Publisher: John Wiley and Sons
Year: 1994
Tongue: English
Weight: 323 KB
Volume: 74
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19941101)74:9+<2662::aid-cncr2820741813>3.0.co;2-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Barriers to clinical trials: Part III: K

Barriers to clinical trials: Part III: Knowledge and attitudes of health care providers

✍ Edward G. Mansour 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 458 KB 👁 1 views

The role of clinical trials is becoming extremely important for our understanding of the effects of different therapeutic modalities of cancer treatment and the value of their interactions. Participation of patients in clinical trials remains disappointingly low, with less than 3% of the estimated 1

Gene transfer and therapy clinical trial

Gene transfer and therapy clinical trials – update. Part I: Countries, Diseases, Clinical trial phases, Routes of administration

✍ Thomas Valère 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 183 KB 👁 1 views

Part I\*: Countries, Diseases, Clinical trial phases, Routes of administration ## Countries Countries where clinical trials are being performed or have been approved Gene therapy trials have now been initiated on all ®ve continents but the large majority of trials are being performed in the USA

Barriers and enablers to returning to wo

Barriers and enablers to returning to work from long-term sickness absence: Part I—A quantitative perspective

✍ Belinda J. Board; Jennifer Brown 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 177 KB 👁 1 views

## Abstract ## Background Long‐term sickness absence (LTSA) in the United Kingdom labor market has become a major health issue in recent years. In contrast to short‐term sickness absence, rates for LTSA have been on the increase. This paper, part 1 of a two‐part paper, identifies individual domain

Prospective randomized clinical trial to

Prospective randomized clinical trial to evaluate the optimal dose of 131I for remnant ablation in patients with differentiated thyroid carcinoma

✍ Adam Taube; Göran Lundell 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 100 KB 👁 2 views

outcome of 87 patients with gallbladder carcinoma (GBC) who underwent surgery. The authors concluded that surgical resection provides significantly better survival than a bypass procedure or exploratory laparotomy alone. Because radical tumor resection may significantly improve survival as compared

Letter to the Editor: Survival analysis

Letter to the Editor: Survival analysis of randomized clinical trials adjusted for patients who switch treatments by M. G. Law and J. M. Kaldor, Statistics in Medicine, 15, 2069–2076 (1996)

✍ I. R. White 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 125 KB 👁 2 views

Law and Kaldor address the important question of clinical trials with survival outcomes in which subjects may change in a non-randomized manner from one randomized treatment to the other during the course of follow-up. These changes make the treatment experience of the two randomized groups more sim